Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 15Recruiting 3Not yet recruiting 3Withdrawn 2Unknown 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Thoracic 3Lymphoid 3Genitourinary 3CNS 3Plasma cell 2Myeloid 2Breast 2Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Stage IA Uterine Sarcoma 1

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Therapeutics × Gynecologic × Clear all
NCT01367301 2023-08-21

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

Albert Einstein College of Medicine

Phase NA Terminated
14 enrolled 5 charts
GynecologicSarcoma

Stage IA Uterine Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡